OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
June 02, 2020
The global COVID-19 pandemic has highlighted the need for the pharmaceutical industry to strengthen its supply chain.
Pharma’s reputation is being boosted in light of the current COVID-19 pandemic efforts.
May 15, 2020
As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
May 02, 2020
Industry must never become complacent about the safety of drug products and should seek to continually perform surveillance even if the drug is well-established.
In light of the hype around chloroquine and hydroxychloroquine as potential COVID-19 treatments, it is important to remember that drug repurposing should never be rushed, irrespective of the urgency of the situation.
Reformulation strategies can provide drug developers with a head start to achieve promising options that benefit the patient.